Status:
COMPLETED
Retrospective Brazilian Study of Fulvestrant in Advanced Breast Cancer
Lead Sponsor:
AstraZeneca
Collaborating Sponsors:
Dendrix - Scientific Information Architecture
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
Characterize the demographic and clinical features, as well as the main treatment results, among patients with advanced breast cancer treated with fulvestrant in Brazil.
Eligibility Criteria
Inclusion
- Positive HR or ER by immunohistochemistry
- Postmenopausal status at the time of treatment with fulvestrant
- Failure of at least one previous endocrine therapy before treatment with fulvestrant.
Exclusion
- Patients who are still undergoing treatment with fulvestrant will not be eligible to participate in the study
Key Trial Info
Start Date :
May 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2009
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00660803
Start Date
May 1 2008
End Date
April 1 2009
Last Update
January 21 2010
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Recife, Pernambuco, Brazil
2
Research Site
Rio de Janeiro, Rio de Janeiro, Brazil
3
Research Site
Porto Alegre, Rio Grande do Sul, Brazil
4
Research Site
São Paulo, São Paulo, Brazil